GALDY Stock — GALDERMA GROUP AG

GALDERMA GROUP AG (GALDY)

Updated October 16, 2026.

GALDY is a Stock. its distribution rate is 0.21%, its trailing-12-month yield is 0.21%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 159.3% over the past 2.3 years, 118.2 points ahead of SPY at 41.1%.

Galderma Group AG is a Swiss dermatology company that develops and markets a science-based portfolio of brands and services spanning injectable aesthetics, dermatological skincare, and therapeutic dermatology, with flagship brands including Dysport, Restylane, Sculptra, Cetaphil, and Differin. The company distributes annually at a very modest current rate. This security may appeal to healthcare investors seeking exposure to the dermatology sector with some income component.

GALDY performance versus SPY

Price and return data through 2026-10-16.

Total return is 159.3% over the past 2.3 years, 118.2 points ahead of SPY at 41.1%. Over the past year its total return — price change plus distributions reinvested — is 22.7%. Its deepest 1-year drawdown was 19.9%.

GALDY key facts

Distribution Safety Score™

50 · Unproven

Asset type

Stock

Asset class

Equity

Inception date

07/08/2024

Distribution rate

0.21%

Distribution frequency

Annual

Trailing yield

0.21%

Last close

$42.40 (as of 2026-10-16)

Market cap

$49,436,054,644

Average volume

29315.0

Dividend

$0.08852

Ex-dividend date

04/27/2026

Payment date

05/12/2026

Beta

-0.111

Payout ratio

12.1%

P/E ratio

58.08

Forward P/E

29.9401

EPS

$0.73

How Dividend Vision calculates yield and returns

Distribution rate (0.21%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.21%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

GALDY risks and drawbacks

GALDY's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are annual, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 19.9%.

Who may consider GALDY — and who may not

It is a weaker fit for investors who need monthly cash flow (GALDY pays annual); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on GALDY

• All tickers starting with G

Tagged: Healthcare, Dividend.

Frequently asked questions